 |
Deepak Madhavan, M.D. |
Deepak Madhavan, M.D., associate professor of neurological sciences at UNMC, will discuss cannabidiol and its potential clinical use in treating patients suffering from epilepsy at the next Omaha Science Cafe at 7 p.m. on Tuesday at the Slowdown, 729 N. 14th St.
Cannabidiol is a cannabinoid that is extracted from the Cannabis sativa plant and is distinct from tetrahydrocannabidiol (THC), the cannabinoid that is responsible for the drug-related high from smoking marijuana.
Dr. Madhavan, who also is director of the Nebraska Comprehensive Epilepsy Program and clinical director of the Magnetoencephalography Center at Nebraska Medicine, is currently involved in the oversight of a clinical study that is investigating the use of cannabidiol in patients with drug resistant epilepsy.
Dr. Madhavan, completed his epilepsy fellowship at New York University, focusing on epilepsy surgery and magnetoencephalography. While at NYU, Dr. Madhavan was awarded a research and training fellowship for clinicians from the Epilepsy Foundation of America. In 2009, he founded Midwest Regional Epilepsy Associates, an epilepsy-focused private practice prior to joining UNMC.
Science Cafes involve a face-to-face conversation with a scientist about current science topics. They are open to everyone (21 and older) and take place in casual settings like pubs and coffeehouses. Each meeting is organized around an interesting topic of conversation. A scientist gives a brief presentation followed by a Q-and-A period.
Pizza will be provided for the first 50 people. For more information about Science Cafes, click here.